Resources
11 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 10/19/2023 (updated 4/11/2024)
Implementation IV grantees with tools and strategies
Posted 7/9/2020 (updated 3/28/2024)
This presentation provides tips using examples from the Medicare Rural Hospital Flexibility Program on working with subcontractors, stakeholders and partners in ways to demonstrate outcomes.
Posted 5/27/2020 (updated 3/28/2024)
Please see attached technical modules to help guide you as you work to address the opioid epidemic in your communities. They are a resource for you to identify best practices and implementation models for prevention, treatment, and recovery.
Posted 11/21/2019 (updated 3/28/2024)
North Carolina Harm Reduction Naloxone Log Template
Posted 5/11/2020 (updated 3/28/2024)
This fact sheet describes changes to Oregon Health Authority (OHA) reimbursement for Medication-Assisted Treatment drugs administered to fee-for-service Oregon Health Plan members, effective January 1, 2019.
Posted 7/28/2020 (updated 3/28/2024)
Brandeis University’s Institute for Behavioral Health Opioid Policy Research Collaborative launched the Brandeis Opioid Resource Connector (BORC) website, a comprehensive online resource for communities and local leaders addressing the opioid crisis.
Posted 10/31/2023 (updated 3/28/2024)
This webinar will welcome FY23 MAT Access II and re-welcome FY22 MAT-Access I recipients to the RCORP program, providing grantees an overview of the RCORP program, an introduction to HRSA’s Office of Federal Assistance Management, and information about the technical assistance and evaluation options for the award.
Posted 3/22/2022 (updated 3/27/2024)
The purpose of this document is to provide detailed guidelines of the Nurse Care Manager Model of Office Based Addiction Treatment program for management of substance use disorders, with particular emphasis on treatment of opioid use disorder with buprenorphine (alone and in combination with naloxone) and naltrexone (oral and extended-release injectable formulations).